Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practice

Author： Pamukcu Burak   Lip Gregory YH  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.1, 2011-01, pp. : 131-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PALLAS: limiting indications for dronedarone treatment of atrial fibrillation?

By Doggrell Sheila A   Hancox Jules C  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 6, 2012-04 ,pp. : 867-871

Informa Healthcare

Access to resources Recommend Favorite

Dronedarone: A New Hope for Stroke Prevention in Atrial Fibrillation?

By Shantsila Alena   Lip Gregory Y.H.  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 6, 2011-12 ,pp. : 355-356

Adis International

Access to resources Recommend Favorite

Dronedarone for the Treatment of Atrial Fibrillation: A NICE Single Technology Appraisal

By McKenna Claire  

PharmacoEconomics, Vol. 30, Iss. 1, 2012-01 ,pp. : 35-46

Adis International

Access to resources Recommend Favorite

Dronedarone improves ventricular rate control among patients with atrial fibrillation

By  

Inpharma, Vol. 1, Iss. 1660, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Anticoagulation during Cardioversion in Patients with Atrial Fibrillation: Current Clinical Practice

By Stellbrink Christoph   Schimpf Thomas  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 3, 2005-01 ,pp. : 155-162

Adis International

Access to resources Recommend Favorite